216
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Clinicians’ Intention to Submit Microbiological Pathogenic Test Before Antibiotics Use and Its Influencing Factors: New Evidence from the Perspective of Hospital Management

, ORCID Icon, , &
Pages 3013-3023 | Published online: 11 Jun 2022

References

  • Goossens H, Ferech M, Vander SR, Elseviers M; ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet. 2005;365(9459):579–587. doi:10.1016/S0140-6736(05)
  • Sabtu N, Enoch DA, Brown NM. Antibiotic resistance: what, why, where, when and how? Br Med Bull. 2015;116:105–113. doi:10.1093/bmb/ldv041
  • OECD [Website on the Internet]. Antimicrobial resistance policy insights. Paris; 2016. Available from: https://www.oecd.org/health/health-systems/AMR-Policy-Insights-November2016.pdf. Accessed February 9, 2022.
  • WHO [Website on the Internet]. Antimicrobial resistance. Geneva; 2021. Available from: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Accessed February 9, 2022.
  • Karami Z, Knoop BT, Dofferhoff ASM, et al. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infect Dis. 2021;53(2):102–110. doi:10.1080/23744235.2020.1839672
  • Langford BJ, So M, Raybardhan S, et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. Clin Microbiol Infect. 2020;26(12):1622–1629. doi:10.1016/j.cmi.2020.07.016
  • Wang L, Amin AK, Khanna P, et al. An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London. J Antimicrob Chemother. 2021;76(3):796–803. doi:10.1093/jac/dkaa475
  • Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19: a systematic review and meta-analysis. J Infect. 2020;81(2):266–275. doi:10.1016/j.jinf.2020.05.046
  • Song M, Nie L, Wu X. The influence of comprehensive intervention on submission rate of clinical pathogenic microorganism specimens. Mod Prev Med. 2015;42(16):3066–3068.
  • Sanchez GV, Fleming-Dutra KE, Roberts RM, Hicks LA. Core elements of outpatient antibiotic stewardship. MMWR Recomm Rep. 2016;65(6):1–12. doi:10.15585/mmwr.rr6506a1
  • NCDC [Website on the Internet]. National treatment guidelines for antimicrobial use in infectious diseases. New Delhi; 2016. Available from: https://ncdc.gov.in/WriteReadData/l892s/File622.pdf. Accessed February 9, 2022.
  • People’s medical publishing house [Website on the Internet]. Guiding principles of clinical application of antibiotics. Beijing; 2015. Available from: http://www.gov.cn/xinwen/2015-08/27/content_2920799.htm. Accessed February 9, 2022.
  • The People’s Republic of China [Website on the Internet]. Notice of the general office of the national health commission on the issuance of the national target for improving medical quality and safety in 2021. Beijing; 2021. Available from: http://www.gov.cn/zhengce/zhengceku/2021-02/22/content_5588240.htm. Accessed February 9, 2022.
  • Liu S, Li JS, Shi JX, et al. Clinical effect of comprehensive intervention on submission rates of microbiological specimens. Chin J Infect Control. 2018;17(2):5.
  • Davey P, Marwick CA, Scott CL, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;2(2):CD003543. doi:10.1002/14651858.CD003543.pub3
  • Park HS. Relationships among attitudes and subjective norms: testing the theory of reasoned action across cultures. Commun Stud. 2000;51(2):162–175. doi:10.1080/10510970009388516
  • Wang H, Feng Z, Xu S. Impacts of characteristic personal behaviors on physicians’ drug prescription behaviors based on KABP model. Chin J Hospital Admin. 2012;2012:544–547.
  • Wan Y, Cao J, Liu Y, Gao K, Liu Y, Chen J. Application of quality control circle to improve pathogen detection rate before therapeutic use of antibacterial drugs in surgical inpatients. Chin J Nosocomiology. 2017;27(4):4.
  • Helou RI, Foudraine DE, Catho G, Peyravi Latif A, Verkaik NJ, Verbon A. Use of stewardship smartphone applications by physicians and prescribing of antimicrobials in hospitals: a systematic review. PLoS One. 2020;15(9):e0239751. doi:10.1371/journal.pone.0239751
  • Zhao L, Gao T. Application of PDCA method in the management of antimicrobial use intensity in our department. Chin Pharm. 2014;5:410–412.
  • Bertollo LG, Lutkemeyer DS, Levin AS. Are antimicrobial stewardship programs effective strategies for preventing antibiotic resistance? A systematic review. Am J Infect Control. 2018;46(7):824–836. doi:10.1016/j.ajic.2018.01.002
  • Murray PR. The clinician and the microbiology laboratory. Arch Pathol Lab Med. 2015;191. doi:10.1016/B978-1-4557-4801-3.00016-3
  • Agresti A. An Introduction to Categorical Data Analysis. New York: John Wiley; 2019.
  • Anderson CJ, Rutkowski L. Multinomial Logistic Regression. CA: Sage Publications; 2008.
  • Katsios CM, Burry L, Nelson S, et al. An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients. Crit Care. 2012;16(6):R216. doi:10.1186/cc11854
  • Samarkos M, Skouloudi M, Anastasopoulou A, Markogiannakis A. Restricted antimicrobial prescribing in an area of highly prevalent antimicrobial resistance. Infect Dis Now. 2021;51(6):526–531. doi:10.1016/j.idnow.2021.05.002
  • Cox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017;23(11):812–818. doi:10.1016/j.cmi.2017.07.010
  • Hansen MJ, Carson PJ, Leedahl DD, Leedahl ND. Failure of a best practice alert to reduce antibiotic prescribing rates for acute sinusitis across an integrated health system in the midwest. J Manag Care Spec Pharm. 2018;24(2):154–159. doi:10.18553/jmcp.2018.24.2.154
  • Qiao J, Qin Y, Chen F, Yao H, Zeng T. Application of target management in improving the inspection rate of pathogenic microbial specimens. Pract J Med Pharm. 2021;4:1243–1247.
  • Goff DA, Kullar R, Goldstein EJC, et al. A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail. Lancet Infect Dis. 2017;17(2):e56–e63. doi:10.1016/S1473-3099(16)30386-3
  • Amdany HK, McMillan M. Metronidazole intravenous formulation use in in-patients in Kapkatet District Hospital, Kenya: a best practice implementation project. JBI Evid Synth. 2014;12(3):419–432. doi:10.11124/jbisrir-2014-1381
  • Li Y, Zhao J. Conduct an investigation and analysis of the application of antimicrobial drugs in hospitalized patients before and after antimicrobial management. Today Nurse. 2016;29:1805–1810.
  • Grąźlewska W, Ferra B, Rudzińska M, Holec-Gąsior L. Borrelia burgdorferi BmpA-BBK32 and BmpA-BBA64: new recombinant chimeric proteins with potential diagnostic value. Pathogens. 2021;10(6):767. doi:10.3390/pathogens10060767
  • Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect. 2021;27(1):9–11. doi:10.1016/j.cmi.2020.09.025
  • Samore MH, Bateman K, Alder SC, et al. Clinical decision support and appropriateness of antimicrobial prescribing: a randomized trial. JAMA. 2005;294(18):2305–2314. doi:10.1001/jama.294.18.2305
  • Lin J, Chen L, Jiang W, Zhang H, Shi Y, Cai W. Rapid detection of low-level HeLa cell contamination in cell culture using nested PCR. J Cell Mol Med. 2019;23(1):227–236. doi:10.1111/jcmm.13923
  • Pakyz AL, Moczygemba LR, VanderWielen LM, Edmond MB, Stevens MP, Kuzel AJ. Facilitators and barriers to implementing antimicrobial stewardship strategies: results from a qualitative study. Am J Infect Control. 2014;42(10 Suppl):S257–S263. doi:10.1016/j.ajic.2014.04.023
  • Burke JP. Antibiotic resistance–squeezing the balloon? JAMA. 1998;280(14):1270–1271. doi:10.1001/jama.280.14.1270
  • WHO [Website on the Internet]. Global Antimicrobial Resistance and Use Surveillance System. Geneva; 2015. Available from: https://www.who.int/initiatives/glass. Accessed February 9, 2022.
  • Hoff BM, Ford DC, Ince D, et al. Implementation of a mobile clinical decision support application to augment local antimicrobial stewardship. J Pathol Inform. 2018;9:10. doi:10.4103/jpi.jpi_77_17
  • Ohl CA, Luther VP. Antimicrobial stewardship for inpatient facilities. J Hosp Med. 2011;6(Suppl 1):S4–S15. doi:10.1002/jhm.881
  • MacDougall C, Polk RE. Antimicrobial stewardship programs in health care systems. Clin Microbiol Rev. 2005;18(4):638–656. doi:10.1128/CMR.18.4.638-656.2005
  • Walia K, Ohri VC, Madhumathi J, Ramasubramanian V. Policy document on antimicrobial stewardship practices in India. Indian J Med Res. 2019;149(2):180–184. doi:10.4103/ijmr.IJMR_147_18
  • Du M. Effect of information technology on management of reasonable use of antibiotics in four years. Chin J Nosocomiology. 2016;26(18):4.